| 1/3/2024 | 3004900008 | TENECTEPLAZA, LYOPHILISATE FOR THE PREPARATION OF A SOLUTION FOR INTRAVENOUS ADMINISTRATION 50 MG (JSC PHARMASINTEZ-NORD, RUSSIA) SERIES 10722, EXPIRE TIME 07.2024, DOES NOT CONTAIN NARCOTIC SUBSTANCES OR THEIR PRECURSORS, FOR CLINICAL STUDIES IN THE TERR | XXXXXXXXXX | 2 | N/A | 0 | Uzbekistan | NA |
| 1/3/2024 | 3004900008 | METALYZE, LYOPHILISATE FOR THE PREPARATION OF A SOLUTION FOR INTRAVENOUS ADMINISTRATION 50 MG (BOEHRINGER INGELHEIM INTERNATIONAL GMBH, GERMANY) BATCH 020923, EXPIRE BY 31.05.2025, DOES NOT CONTAIN NARCOTIC SUBSTANCES AND THEIR PRECURSORS, FOR CLINICAL ST | XXXXXXXXXX | 2 | N/A | 0 | Uzbekistan | NA |
| 11/9/2023 | 3004900002 | SODIUM OXYBATE (SODIUM OXYBUTYRATE), SOLUTION FOR INTRAVENOUS AND INTRAMUSCULAR ADMINISTRATION, 200 MG/ML, 5 ML - AMPOULES (5 PCS) - CARDBOARD PACKS. ONLY 3 | XXXXXXXXXX | 0 | 0 | 53.01 | Uzbekistan | TASHKENT |
| 10/31/2023 | 3004310000 | RINLIZ (INSULIN LISPRO) - SOLUTION FOR INTRAVENOUS AND SUBCUTANEOUS ADMINISTRATION, 100 IU/ML, SERIES 70223. ACTIVE SUBSTANCE: HUMAN INSULIN 100 IU. VSP | XXXXXXXXXX | 0 | 0 | 17280 | Uzbekistan | DOMODEDOVO |
| 9/18/2023 | 3004900002 | MEDICINE PACKAGING FOR RETAIL SALE: PANAVIR (SOLUTION FOR INTRAVENOUS ADMINISTRATION, 0.04 MG/ML) (AMPOULES) 5 ML, No. 5., NOT VITAL WITH | XXXXXXXXXX | 0 | 0 | 182016 | Uzbekistan | TASHKENT |
| 9/15/2023 | 3004900008 | TENECTEPLASE, LYOPHILIZATE FOR PREPARATION OF SOLUTION FOR INTRAVENOUS ADMINISTRATION 50 M | XXXXXXXXXX | 0 | 0 | 17.47 | Uzbekistan | UNkNOwN |
| 9/15/2023 | 3004900008 | METALISE. LYOPHILIZATE FOR PREPARATION OF SOLUTION FOR INTRAVENOUS ADMINISTRATION 50 MG, | XXXXXXXXXX | 0 | 0 | 6107.68 | Uzbekistan | UNkNOwN |
| 6/14/2023 | 3004310000 | RINLIZ (INSULIN LISPRO) - SOLUTION FOR INTRAVENOUS AND SUBCUTANEOUS ADMINISTRATION, 100 IU/ML, SERIES 70223. ACTIVE SUBSTANCE: HUMAN INSULIN 100 IU, VSP | XXXXXXXXXX | 0 | 0 | 9600 | Uzbekistan | DOmOdedOvO |